Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Ambrisentan
Locations
2
United States
University of North Carolina Medical Center
Chapel Hill, North Carolina, United States
Medical Univerrsity of South Carolina
Charleston, South Carolina, United States
Start Date
November 1, 2008
Primary Completion Date
April 1, 2011
Completion Date
November 1, 2011
Last Updated
August 2, 2018
NCT07073820
NCT06899815
NCT07462260
NCT07057466
NCT05935605
NCT06947460
Lead Sponsor
Medical University of South Carolina
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions